Evidence map›Paper›PMID 36014614›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Impact of Nanolayered Material and Nanohybrid Modifications on Their Potential Antibacterial Activity.

Hasna Abdullah Alali, Osama Saber, Mahmoud Mohamed Berekaa, Doaa Osama, Mohamed Farouk Ezzeldin, Nagih M Shaalan, Abdulaziz Abdulrahman AlMulla

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hasna Abdullah AlaliDepartment of Physics, College of Science, King Faisal University, P.O. Box 400, Al-Ahsa 31982, Saudi Arabia.
Osama SaberDepartment of Physics, College of Science, King Faisal University, P.O. Box 400, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-1840-2732
Mahmoud Mohamed BerekaaDepartment of Environmental Health, Collage of Public Health, Imam Abdulrahman Bin Faisal University (IAU), P.O. Box 1982, Dammam 31441, Saudi Arabia.
Doaa OsamaDepartment of Physics, College of Science, King Faisal University, P.O. Box 400, Al-Ahsa 31982, Saudi Arabia.
Mohamed Farouk EzzeldinEgyptian Petroleum Research Institute, Nasr City, P.O. Box 11727, Cairo 11765, Egypt.
Nagih M ShaalanDepartment of Physics, College of Science, King Faisal University, P.O. Box 400, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0001-5419-6043
Abdulaziz Abdulrahman AlMullaDepartment of Environmental Health, Collage of Public Health, Imam Abdulrahman Bin Faisal University (IAU), P.O. Box 1982, Dammam 31441, Saudi Arabia.
King Faisal University · SAImam Abdulrahman Bin Faisal University · SA

Funding

Deanship of Scientific Research at King Faisal University under Empowered Female Researcher Track GRANT 1097
6 · The paper itself

Abstract

Due to an escalating increase in multiple antibiotic resistance among bacteria, novel nanomaterials with antimicrobial properties are being developed to prevent infectious diseases caused by bacteria that are common in wastewater and the environment. A series of nanolayered structures and nanohybrids were prepared and modified by several methods including an ultrasonic technique, intercalation reactions of fatty acids, and carbon nanotubes, in addition to creating new phases based on zinc and aluminum. The nanomaterials prepared were used against a group of microorganisms, including

Indexed as

antimicrobial resistancelayered double hydroxide (LDH)modified nanohybridsnanotubes and fatty acidsultrasonicZn/Al nanolayered

Identifiers

PMID36014614
PMCPMC9416148
OpenAlexW4291017255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.